ICICI Pru Life Q1: standalone PAT +27.8% to ₹386 Cr, VNB margin expands 220bps to 26.7%
PAT +27.8% YoY · revenue +14.7% · margins expanding · beat vs street
₹28,512 Cr
+14.7% YoY
₹386 Cr
+27.8% YoY
1.35%
-55.5pp YoY
₹2.66
ICICI Prudential Life posted standalone Q1-FY27 (Jun-2026) profit after tax of ₹386 Cr, up 27.8% YoY from ₹302 Cr — ahead of the 15-20% FY27 PAT growth the street had modelled. This is a standalone-only print: as a life insurer with no material subsidiaries, the company reports and the board approves only standalone results. The headline profitability metric, Value of New Business (VNB), rose 24.9% YoY to ₹571 Cr with the VNB margin expanding 220bps to 26.7% (from 24.5%), comfortably clearing the '24%+ margin' litmus test analysts had flagged. Management provided no quantitative FY27 guidance on its last call (a deliberate 'wait-and-watch' stance amid macro uncertainty), but its qualitative aim of 'sustainable absolute VNB growth balancing profitability and risk' was delivered this quarter.
Q1 FY-2027 vs prior quarters
The profit lift came from higher shareholders' investment income, improved surplus generation on the in-force book, and lower new-business strain — PBT rose to ₹431 Cr from ₹345 Cr. The margin expansion is a mix story: protection is the engine, with overall protection APE up 45.7% and retail protection APE up 60.4% YoY (a third consecutive quarter of >40% growth following GST exemption on protection products), lifting retail new-business sum assured 45.9% to ₹1.13 lakh cr. Notably the margin gain landed despite a GST headwind — disallowance of input-tax credit on retail business pushed non-linked opex up 28% YoY, yet the savings cost-to-premium ratio still fell 50bps to 13.6%. There were no exceptional or one-off items on either side, so the reported +27.8% PAT growth equals the underlying number.
The stock went into the print at ₹526.55, up 8.3% over the past month of trading.
For context: revenue is at a 6-quarter high.
Management provided no quantitative guidance for FY2027, citing significant market volatility and geopolitical uncertainty, adopting a 'wait and watch' approach. The core strategic focus is on delivering sustainable absolute VNB growth by balancing profitability and risk. Growth will be pursued through a 'micro-market'
Topline was steady rather than spectacular: total premium ₹10,251 Cr (+14.5%), new-business premium ₹4,866 Cr (+21.3% on 13.2% policy-count growth), and APE ₹2,136 Cr (+14.6%). The QoQ optics (PAT -36.6% vs Q4's ₹609 Cr) are pure seasonality — Q4 is always the peak selling quarter for Indian life insurers — and should be ignored. Alongside the numbers the board approved renaming the company to 'ICICI Life Insurance Ltd' and Prudential's (PCHL) reclassification from promoter to investor, both pending IRDAI approval; management stresses operations, strategy and governance are unchanged. Balance sheet remains strong (solvency 225.4% vs 150% required, AUM ₹3.34 lakh cr, zero NPAs). The one soft spot to track is persistency, where the 25th-month ratio slipped to 77.0% from 83.4% a year ago.
What to watch
W1
VNB margin durability — 26.7% (+220bps) was protection-mix led; watch whether the 45.7% protection-APE momentum and margin hold through FY27 as the GST tailwind normalises
W2
Persistency slippage — 25th-month ratio fell to 77.0% from 83.4% YoY and 13th-month eased to 84.0% from 86.0%; a leading quality-of-book signal to monitor
W3
IRDAI approval of the name change to 'ICICI Life Insurance Ltd' and Prudential's promoter-to-investor reclassification (pending; not yet reflected in accounts)
Life insurer, standalone-only filing (no consolidated statement exists). Statutory statement in ₹ Lakh; company summary P&L in ₹ billion (1bn=100Cr), converted to ₹ Cr. revenueFromOperations = net premium earned ₹9,749 Cr + investment income ₹18,763 Cr; that investment income is largely a unit-linked MTM offset by ₹16,919 Cr change in actuarial liability, so the meaningful topline is premium. No exceptional items either side (reported growth = underlying). QoQ figures distorted by Q4 seasonality and Q4's negative MTM investment income.
Informational and educational content only. Not investment advice.